You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ChAdOx1

Showing 1 - 25 of 138
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Herpes Zoster Trial in Halifax (Recombinant Zoster Vaccine (Adenovirus Vector) (ChAdOx1-VZV), Zoster Vaccine Recombinant,

Not yet recruiting
  • Herpes Zoster
  • Recombinant Zoster Vaccine (Adenovirus Vector) (ChAdOx1-VZV)
  • +5 more
  • Halifax, Canada
    Canadian Center for Vaccinology
Aug 6, 2023

Coronavirus Trial in Oxford (ChAdOx1 nCov-19)

Completed
  • Coronavirus
  • ChAdOx1 nCov-19
  • Oxford, United Kingdom
    CCVTM, University of Oxford, Churchill Hospital
Oct 21, 2022

Healthy Adult Volunteers Trial in Taipei City (ChAdOx1-nCov-19 (Astra-Zeneca), SARS-CoV-2 messenger RNA-1273 (Moderna) vaccine)

Completed
  • Healthy Adult Volunteers
  • ChAdOx1-nCov-19 (Astra-Zeneca)
  • SARS-CoV-2 messenger RNA-1273 (Moderna) vaccine
  • Taipei City, X, Taiwan
    National Taiwan University Hospital
Oct 16, 2022

HIV Trial in Oxford (ChAdOx1.tHIVconsv1 (C1), MVA.tHIVconsv3 (M3), MVA.tHIVconsv4 (M4))

Completed
  • HIV
  • ChAdOx1.tHIVconsv1 (C1)
  • +2 more
  • Oxford, United Kingdom
    Centre for Clinical Vaccinology and Tropical Medicine, Churchill
Aug 10, 2022

Healthy Trial in Oxford (ChAdOx1.HTI and MVA.HTI)

Completed
  • Healthy
  • ChAdOx1.HTI and MVA.HTI
  • Oxford, United Kingdom
    Centre for Clinical Vaccinology and Tropical Medicine, Churchill
Aug 31, 2022

Hepatitis B, Healthy Trial in United Kingdom (ChAdOx1-HBV)

Completed
  • Hepatitis B
  • Healthy
  • ChAdOx1-HBV
  • Southampton, Hampshire, United Kingdom
  • +3 more
Jul 22, 2022

Ebola Trial in Oxford (ChAdOx1 biEBOV)

Recruiting
  • Ebola
  • ChAdOx1 biEBOV
  • Oxford, United Kingdom
    Centre for Clinical Vaccinology and Tropical Medicine, Churchill
Aug 10, 2022

Coronavirus Trial in United Kingdom (ChAdOx1 nCoV-19, MenACWY, ChAdOx1 nCoV-19 full boost)

Active, not recruiting
  • Coronavirus
  • ChAdOx1 nCoV-19
  • +8 more
  • Southampton, Hampshire, United Kingdom
  • +5 more
Jan 20, 2022

Rift Valley Fever Trial in Oxford (ChAdOx1 RVF)

Completed
  • Rift Valley Fever
  • ChAdOx1 RVF
  • Oxford, United Kingdom
    CCVTM, University of Oxford, Churchill Hospital
Apr 27, 2022

HIV Infection Trial in Badalona (ChAdOx1.HTI at week 0, ConM SOSIP.v7 at weeks 4, 12 and 28, and MVA.HTI at week 22 (CSSMS).,

Recruiting
  • HIV Infection
  • ChAdOx1.HTI at week 0, ConM SOSIP.v7 at weeks 4, 12 and 28, and MVA.HTI at week 22 (CSSMS).
  • Normal saline solution
  • Badalona, Barcelona, Spain
    Germans Trias i Pujol Hospital
Jul 11, 2022

Chadox1 Ncov-19 Vaccine: Rapid Systematic Review and Meta

Active, not recruiting
  • ChAdOx1 nCoV-19 Vaccine
  • ChAdOx1 nCoV-19 vaccine
  • Assiut, Egypt
    Aliae AR Mohamed-Hussein
Sep 18, 2021

Ebola Trial in Bagamoyo (ChAdOx1 biEBOV)

Recruiting
  • Ebola
  • ChAdOx1 biEBOV
  • Bagamoyo, Tanzania
    Bagamoyo Clinical Trial Facility
May 17, 2022

Chikungunya, Zika Trial in Monterrey (CHIK low dose, CHIK mid dose, CHIK high dose)

Completed
  • Chikungunya
  • Zika
  • CHIK low dose
  • +6 more
  • Monterrey, Nuevo León, Mexico
    Hospital Universitario "Dr. José Eleuterio González" de la Unive
Mar 22, 2022

COVID-19 Trial in Manila (EuCorVac-19, ChAdOx1)

Recruiting
  • COVID-19
  • EuCorVac-19
  • ChAdOx1
  • Manila, Philippines
    Trial site
Oct 27, 2022

COVID-19 Trial in Vienna (Ad26COVS1, ChAdOx1 SARS2 Vaccine, BNT162B2)

Active, not recruiting
  • COVID-19
  • Vienna, Austria
    Medicial University of Vienna
Apr 12, 2022

Coronavirus Trial in United Kingdom (ChAdOx1 nCoV-19 (Abs 260), MenACWY vaccine, ChAdOx1 nCoV-19 (Abs 260) + 2.2x10^10vp (qPCR)

Active, not recruiting
  • Coronavirus
  • ChAdOx1 nCoV-19 (Abs 260)
  • +8 more
  • Southampton, Hampshire, United Kingdom
  • +19 more
Jan 20, 2022

COVID-19 Vaccination, Inflammation, Vaccine Immune Response Trial in Suwon, Seoul (either BNT162b2 or ChAdOx1 vaccine)

Recruiting
  • COVID-19 Vaccination
  • +3 more
  • either BNT162b2 or ChAdOx1 vaccine
  • Suwon, Gyeonggi-do, Korea, Republic of
  • +2 more
Apr 6, 2022

HPV Infection, CIN1 Trial in Belgium, Estonia, United Kingdom (ChAdOx1-HPV, MVA-HPV, Placebo)

Active, not recruiting
  • HPV Infection
  • CIN1
  • ChAdOx1-HPV
  • +2 more
  • Antwerp, Belgium
  • +15 more
Jan 9, 2023

HIV Vaccine, HIV-1-infection Trial in Chapel Hill, Durham (C62, C1C62, Placebo)

Recruiting
  • HIV Vaccine
  • HIV-1-infection
  • C62
  • +4 more
  • Chapel Hill, North Carolina
  • +1 more
Oct 27, 2022

SARS-CoV-2 Trial in Vitória (Half dose of ChAdOx1 nCoV-19 (AZD1222), Standard dose of ChAdOx1 nCoV-19 (AZD1222))

Recruiting
  • SARS-CoV-2
  • Half dose of ChAdOx1 nCoV-19 (AZD1222)
  • Standard dose of ChAdOx1 nCoV-19 (AZD1222)
  • Vitória, Espirito Santo, Brazil
    Federal University of Espirito Santo
Sep 24, 2021

Sudan Ebola Virus Vaccines Trial (CAd3, ChAdox1, rVSV-SUDV)

Not yet recruiting
  • Sudan Ebola Virus Vaccines
  • CAd3
  • +3 more
  • (no location specified)
Jun 8, 2023

NSCLC (NSCLC) Trial in United Kingdom (ChAdOx1-MAGEA3-NYESO, MVA-MAGEA3, Standard of care treatment)

Recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • ChAdOx1-MAGEA3-NYESO
  • +2 more
  • Birmingham, United Kingdom
  • +7 more
Dec 16, 2021

Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients

Not yet recruiting
  • Covid-19 Pandemics
  • Tuberculosis
  • Pfizer-BioNTech COVID-19 vaccine
  • +2 more
  • Mae Sot, Tak, Thailand
    Shoklo Malaria Research Unit (SMRU)
Oct 21, 2022

RVF, Rift Valley Fever Trial in Entebbe (ChAdOx1 RVF, Saline)

Not yet recruiting
  • RVF
  • Rift Valley Fever
  • ChAdOx1 RVF
  • Saline
  • Entebbe, Uganda
    MRC/UVRI and LSHTM Uganda Research Unit
Mar 1, 2022

HIV-1-infection Trial in Brazil, United States (ChAdOx1.tHIVconsv1, ChAdOx1.HIVconsv62, MVA.tHIVconsv3)

Not yet recruiting
  • HIV-1-infection
  • ChAdOx1.tHIVconsv1
  • +7 more
  • San Diego, California
  • +11 more
Oct 4, 2023